Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: May 28, 2009


Eric Schadt has become chief scientific officer of Pacific Biosciences, a new position (see article in this issue). He joins the company from Rosetta Inpharmatics, a subsidiary of Merck in Seattle, where he was executive scientific director of genetics. Prior to that he was a senior research scientist at Roche Bioscience. Schadt holds a PhD in biomathematics and an MA in pure mathematics from the University of California, Los Angeles, and a BA in applied mathematics and computer science from California Polytechnic State University.

Frank Massam has joined Population Genetics Technologies as vice president of business development. Previously, he held senior business development positions with Incyte Genomics and Pharmagene and was responsible for strategic planning and new business development at Agilent Technologies.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.